11431240

Source:http://linkedlifedata.com/resource/pubmed/id/11431240

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018546, umls-concept:C0036341, umls-concept:C0085631, umls-concept:C0087111, umls-concept:C0171023, umls-concept:C0205178, umls-concept:C0442117, umls-concept:C1707455
pubmed:issue	7
pubmed:dateCreated	2001-6-29
pubmed:abstractText	The authors evaluated the comparative efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular placebo for the treatment of acute agitation in schizophrenia.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370512
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines, http://linkedlifedata.com/resource/pubmed/chemical/Haloperidol, http://linkedlifedata.com/resource/pubmed/chemical/Pirenzepine, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/olanzapine
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0002-953X
pubmed:author	pubmed-author:AlakaK JKJ, pubmed-author:BernardiCC, pubmed-author:BirkettMM, pubmed-author:BradleyPP, pubmed-author:BreierAA, pubmed-author:DavidS RSR, pubmed-author:FerchlandII, pubmed-author:KruegerJJ, pubmed-author:MeehanKK, pubmed-author:ReinsteinMM, pubmed-author:SanLL, pubmed-author:SaundersJ CJC, pubmed-author:WrightPP
pubmed:issnType	Print
pubmed:volume	158
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1149-51
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:11431240-Acute Disease, pubmed-meshheading:11431240-Adolescent, pubmed-meshheading:11431240-Adult, pubmed-meshheading:11431240-Antipsychotic Agents, pubmed-meshheading:11431240-Benzodiazepines, pubmed-meshheading:11431240-Dose-Response Relationship, Drug, pubmed-meshheading:11431240-Double-Blind Method, pubmed-meshheading:11431240-Drug Administration Schedule, pubmed-meshheading:11431240-Female, pubmed-meshheading:11431240-Haloperidol, pubmed-meshheading:11431240-Humans, pubmed-meshheading:11431240-Injections, Intramuscular, pubmed-meshheading:11431240-Male, pubmed-meshheading:11431240-Pirenzepine, pubmed-meshheading:11431240-Placebos, pubmed-meshheading:11431240-Psychiatric Status Rating Scales, pubmed-meshheading:11431240-Psychomotor Agitation, pubmed-meshheading:11431240-Schizophrenia, pubmed-meshheading:11431240-Schizophrenic Psychology, pubmed-meshheading:11431240-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
pubmed:affiliation	Lilly Research Centre, Eli Lilly Company, Surrey, UK.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study